Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 17, 2026
SPXS Declines 11.6% in 30 Days and 13.9% Over the Quarter as the S&P 500 Advances

SPXS Declines 11.6% in 30 Days and 13.9% Over the Quarter as the S&P 500 Advances

Key Takeaways

  • SPXS fell approximately 11.6% over the trailing 30 days, moving from a closing price of $26.98 to a latest price near $23.86, as the S&P 500 advanced.
  • Over the trailing three-month period, the fund declined roughly 13.9%, extending a downward trend driven by broad large-cap equity strength.
  • SPXS is a leveraged inverse exchange-traded fund (ETF) that seeks 300% of the inverse of the S&P 500 Index's daily return; it does not hold individual stocks in the traditional sense.
  • The fund's portfolio is dominated by cash and treasury instruments plus S&P 500 index swaps, so index-level moves, not single-stock earnings, drive performance.
  • Daily rebalancing creates compounding effects that can cause multi-day returns to diverge from a simple -3x multiple of the index's cumulative move.
  • Primary risks include continued equity-market upside, elevated volatility, and the costs of maintaining daily inverse exposure.

Understanding SPXS and Its Portfolio Exposure

SPXS is an exchange-traded fund (ETF) launched in November 2008 and managed by Rafferty Asset Management. It seeks daily investment results, before fees and expenses, of 300% of the inverse (opposite) of the daily performance of the S&P 500 Index. In practice, a 1% daily decline in the S&P 500 is designed to produce roughly a 3% gain for the fund before costs, while a 1% daily gain is designed to produce roughly a 3% loss.

The fund carries a net expense ratio of approximately 1.04% and is non-diversified, meaning it can concentrate risk more than a diversified fund. Rather than shorting hundreds of individual stocks, SPXS uses total return swaps on the S&P 500, with cash and government or treasury money market instruments serving as collateral. Its reported holdings typically number around 13 positions; the largest include the Goldman Financial Square Treasury Instruments Fund, Dreyfus Government Cash Management, Dreyfus Treasury Securities Cash Management, and Goldman Sachs Financial Square Government Fund, alongside multiple S&P 500 Index swap legs.

Because the fund has no conventional sector allocation, its effective exposure is inverse to the S&P 500's composition. The index is heavily weighted toward mega-cap technology, communication services, consumer discretionary, and financials. When those segments rise, SPXS tends to fall; when they decline, SPXS tends to rise. This structure explains why the fund's recent behavior has tracked broad index direction rather than any single industry catalyst. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the leveraged ETF space.

Price Performance: 30 Days Versus the Trailing Quarter

Using the latest available price of $23.86 and the closing price of $26.98 from the session nearest 30 calendar days earlier, SPXS declined approximately 11.6%. The move was not a straight line: the fund initially edged higher in late July when the index briefly pulled back, then dropped sharply during a broad early-August equity rally before stabilizing near the lower end of its recent range.

Over the trailing quarter, the decline was larger. From a closing price of $27.69 roughly three months earlier to the latest price of $23.86, SPXS fell approximately 13.9%. The quarter's movement was trend-driven rather than range-bound, with intermittent countertrend bounces when large-cap equities paused or pulled back.

What Drove SPXS Over the Last 30 Days

The dominant driver was a rising S&P 500. A widely followed S&P 500-tracking ETF, the SPDR S&P 500 ETF Trust (SPY), advanced about 4.3% over the same trailing 30-day window. Because SPXS is structured to deliver three times the inverse of the index's daily return, a moderately positive index stretch translates into a much larger percentage decline for the fund.

The sharpest losses occurred during a multi-session rally in large-cap equities in early August. In that stretch, the S&P 500 proxy climbed from roughly $747 to about $771, while SPXS dropped from about $26.57 to $24.08. Mega-cap technology and growth-oriented names, which carry substantial index weight, were central to the advance. Improved risk appetite and reduced demand for downside protection also weakened the tailwind that inverse products sometimes receive during volatile periods.

Because SPXS holds swaps rather than individual stocks, no single underlying company drove the decline. Instead, the performance reflected index-level strength, compounded by daily reset mechanics.

Performance Drivers Over the Trailing Quarter

The trailing three-month trend was shaped by a persistent risk-on tone in U.S. large-cap equities. The S&P 500 advanced approximately 4.8% over the period, with gains concentrated in the index's largest constituents. For an inverse fund, a steady advance is especially challenging because the fund resets its exposure daily; in trending markets, daily rebalancing can create volatility drag, causing multi-period losses that differ from a simple -3x multiple of the index's cumulative return.

Sector rotation also mattered. Leadership from technology, communication services, and growth-oriented shares supported the index's advance and left SPXS with few sustained rallies. Meanwhile, cash-like collateral holdings contributed modest interest income but were not enough to offset the equity-driven decline.

Using Tickeron’s AI Screener for Deeper ETF Analysis

One tool I find useful when evaluating leveraged and inverse ETFs like this is Tickeron’s AI Screener. It helps scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, and AI-generated signals, making it easier to compare momentum and setups across funds. I’ve used it to quickly surface candidates that align with specific criteria, which can be especially helpful for tactical strategies. Explore the AI Screener to narrow the universe and identify opportunities that match your approach.

SPXS Outlook: Key Factors to Monitor

The most important forward-looking factors are the same forces that have driven the fund's recent decline: the direction and pace of the S&P 500, volatility, and the path of daily returns. Investors should monitor Federal Reserve policy expectations, inflation data, and economic growth indicators, since these influence large-cap equity sentiment and the leadership of mega-cap technology and growth shares.

Earnings cycles for the index's largest constituents, sector rotation between growth and value, and changes in equity-market volatility will also be critical. Sustained low volatility and gradual index gains historically create a difficult environment for daily-reset inverse funds, while sharper pullbacks can produce short-term gains. Additionally, fund-specific factors such as net expense ratio, swap costs, and the compounding effects of daily rebalancing remain relevant for any holding period longer than one day.

SPXS is designed for short-term tactical use by investors seeking to hedge or speculate on daily index declines, not as a long-term buy-and-hold position.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SPXS

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for SPXS turns negative, indicating new downward trend

SPXS saw its Momentum Indicator move below the 0 level on July 31, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned negative. In of the 75 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SPXS turned negative on August 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

SPXS moved below its 50-day moving average on July 31, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPXS crossed bearishly below the 50-day moving average on August 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SPXS's RSI Indicator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SPXS advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

SPXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the daily performance of the S&P 500® Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to exchange-traded funds (“ETFs”) that track the index, consistent with the fund’s investment objective. The index is a float-adjusted, market capitalization-weighted index. The fund is non-diversified.
View a ticker or compare two or three
SPXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Inverse Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interact to see
Advertisement
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
CME Group delivered record 2025 revenue of $6.52 billion, up 6% year-over-year. Q4 adjusted EPS of $2.77 exceeded expectations.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Q4 2025 revenue reached $12.5 billion, exceeding expectations, with growth portfolio sales up 16% year-over-year. Full-year 2025 revenue totaled $48.2 billion, supported by Eliquis, Opdivo, and newer products including Breyanzi and Camzyos.
KKR reported Q4 2025 adjusted EPS of $1.12, slightly below the $1.14 consensus estimate. The firm raised a record $129 billion in 2025, surpassing 80% of its $300 billion fundraising goal for 2024–2026.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.